The consortium, led by University of Iceland, consists of 16 partners from 10 countries:
Iceland, Sweden, Spain, Finland, France, Netherlands, Belgium, Ukraine, Czechia and Germany.

The partners, most of them experienced in EU projects, will boost the management of the project, which aims to optimize Therapeutic Epigenetic Enhancement of the Innate Immunity to Effectively Combat Antimicrobial Resistance (AMR).